An Overview of GAMMORA: What You Need to Know
Code Pharma’s Gammora targets HIV by rapidly eliminating infected cells and boosting healthy CD4 cells, as proven in studies. A harmless peptide is introduced, causing viral DNA to over-integrate, leading infected cells to die while healthy cells remain unaffected.
Code Pharma’s Gammora offers a groundbreaking approach by targeting and eliminating HIV-infected cells, unlike traditional antiretroviral therapies that only manage the virus. This innovative treatment could shift HIV/AIDS from a chronic condition to a curable one, improving patient outcomes significantly.
HIV Treatment by Code Pharma
Gammora is a synthetic 16-amino-acid peptide derived from HIV-1 integrase, discovered at the Hebrew University in Israel. It targets and disrupts the mechanism that prevents viral DNA fragments from penetrating cells, leading to the apoptosis of infected cells without harming healthy ones. Unlike antiretrovirals that suppresses HIV DNA integration, Gammora eliminates HIV-infected cells and helps restore healthy CD4 cells, presenting a potential cure for AIDS rather than just managing it as a chronic illness.
Latest News
GAMMORA: A New Era in HIV Treatment
GAMMORA, developed by Code Pharma, is a revolutionary HIV treatment that targets and eliminates infected cells while preserving healthy ones. What sets GAMMORA apart from traditional treatments is its ability
BusinessWire: Code Pharma’s Gammora Demonstrates Potential as a Promising HIV Cure
Code Pharma has reported encouraging eight-week results for its HIV drug, Gammora, suggesting a potential to eradicate the virus at the cellular level. As published on BusinessWire, the preliminary findings